Dexamethasone (Fortecortin) will be acquired from ERN, SA. Laboratories (Barcelona, Spain). The Pharmacy Department of the Hospital Universitari Son Espases will be in charge of developing and conditioning the 4 mg, 2 mg and 1 mg dexamethasone/placebo capsules needed for 12 days of treatment, keeping the researchers blind.

The preparation and conditioning of the capsules will be carried out following the standardized work procedures of the pharmaceutical laboratory and its quality controls, previously authorized by the AEMPS.

The Pharmacy Department of the Hospital Universitari Son Espases will be responsible for identifying the containers and sending them by courier to the participating hospitals. A record of the dispensing of test samples will be kept and will be sent in acknowledgment of receipt for control.

Patients, clinical staff, evaluators of the results as well as the statistical team that will perform the analysis will not know the assigned treatment. A randomization list will be created for each hospital. The randomization sequence will only be known by the Pharmacy Department of the Hospital Universitari Son Espases.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.